Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Revenues $ 205 $ 1,007
Operating expenses:    
Research and development (related party of $527 and $424) 1,898 3,431
Research and development - effect of Settlement Agreement (Note 8) (1,041) 0
Research and development - effect of amendment to Collaboration and License Agreement (Note 8) (1,007) 0
General and Administrative Expense Settlement 3,888 4,243
General and administrative - effect of Settlement Agreement (Note 8) (700) 0
General and administrative - effect of amendment to Collaboration and License Agreement (Note 8) 1,007 0
Total operating expenses 4,045 7,674
Operating loss (3,840) (6,667)
Other income (expense):    
Interest income 8 9
Interest expense 0 (90)
Interest expense - effect of Settlement Agreement (Note 8) 122 0
Royalty income 42 34
Other income (expenses) 3 (4)
Loss on disposal of fixed assets (1) 0
Change in fair value of warrant derivative liability 0 520
Total other income (expense) 174 469
Net loss $ (3,666) $ (6,198)
Loss per common share - basic and diluted (in dollars per share) $ (0.06) $ (0.13)
Weighted-average common shares outstanding - basic and diluted (in shares) 62,968 49,381